| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | 10%+ Owner | Common Stock | 4,555,260 | $109,021,038 | $23.93 | 11 Oct 2024 | as trustee |
| Cartesian Therapeutics, Inc. | 10%+ Owner | Common Stock | 506,377 | $12,119,121 | $23.93 | 11 Oct 2024 | by spouse |
| Cartesian Therapeutics, Inc. | 10%+ Owner | Series A Non-Voting Convertible Preferred Stock | 56,402 | 11 Oct 2024 | as trustee |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | 11 Oct 2024 | 2 | $0 | 4 | 10%+ Owner | 15 Oct 2024, 16:43 |
| RNAC | Cartesian Therapeutics, Inc. | 08 Apr 2024 | 4 | $0 | 4 | 10%+ Owner | 10 Apr 2024, 16:20 |
| RNAC | Cartesian Therapeutics, Inc. | 13 Nov 2023 | 0 | $0 | 3 | 10%+ Owner | 17 Nov 2023, 09:51 |